These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 209223)

  • 1. Surgical considerations in treatment of intraductal carcinoma of the prostate.
    Catalona WJ; Kadmon D; Martin SA
    J Urol; 1978 Aug; 120(2):259-61. PubMed ID: 209223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
    Robinson BD; Epstein JI
    J Urol; 2010 Oct; 184(4):1328-33. PubMed ID: 20723921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal Carcinoma of the Prostate: Morphologic Features, Differential Diagnoses, Significance, and Reporting Practices.
    Magers M; Kunju LP; Wu A
    Arch Pathol Lab Med; 2015 Oct; 139(10):1234-41. PubMed ID: 26414467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Prostate Biopsy Specimens with Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.
    Taneja SS
    J Urol; 2016 Mar; 195(3):627. PubMed ID: 26887707
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraductal Carcinoma of the Prostate.
    Humphrey PA
    J Urol; 2015 Nov; 194(5):1434-5. PubMed ID: 26291925
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.
    Taneja SS
    J Urol; 2017 Dec; 198(6):1208-1211. PubMed ID: 29144942
    [No Abstract]   [Full Text] [Related]  

  • 7. Ductal component - need for personalized follow-up after radical prostatectomy.
    Crisan N; Andras I; Bungardean C; Coman I
    J BUON; 2015; 20(6):1640-1. PubMed ID: 26854466
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolated Intraductal Carcinoma of the Prostate in Prostatectomy Specimens: Report of 2 Cases and Review of the Literature.
    Grypari IM; Logotheti S; Lazaris AC; Kallidonis P; Fokaefs E; Melachrinou M; Zolota V; Tzelepi V
    Int J Surg Pathol; 2020 Dec; 28(8):918-924. PubMed ID: 32456482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SIGNIFICANCE OF INTRADUCTAL CARCINOMA OF THE PROSTATE IN POST-OPERATIVE BIOCHEMICAL RECURRENCE].
    Sakamoto N; Ueda S; Mizoguchi H; Kawahara I; Kobayashi T; Hamaguchi M; Yoshikawa M
    Nihon Hinyokika Gakkai Zasshi; 2017; 108(1):5-11. PubMed ID: 29367511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.
    Khani F; Epstein JI
    Am J Surg Pathol; 2015 Oct; 39(10):1383-9. PubMed ID: 26076065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
    Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
    Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraductal carcinoma of prostate: diagnostic criteria and differential diagnosis].
    Cheng L; Zhao M
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):199-202. PubMed ID: 24842024
    [No Abstract]   [Full Text] [Related]  

  • 13. Papillary carcinoma of prostatic ducts.
    Drake WM; Burrows S
    Urology; 1974 May; 3(5):621-3. PubMed ID: 4133858
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoma of prostatic ducts.
    Vera-Donoso CD; Vidal J; Gómez S; García F; Gallego J; Llopis B; Jiménez-Cruz JF
    Eur Urol; 1991; 19(1):8-11. PubMed ID: 1848822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exophytic papillary prostatic duct adenocarcinoma with endometrioid features, occurring in prostatic urethra after TURP.
    Elgamal AA; Van de Voorde W; Van Poppel H; Vandeursen H; Baert L; Lauweryns J
    Urology; 1994 May; 43(5):737-42. PubMed ID: 7513110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal carcinoma of the prostate: a comprehensive and updated review.
    Tsuzuki T
    Int J Urol; 2015 Feb; 22(2):140-5. PubMed ID: 25358604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
    Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
    Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.
    Trinh VQ; Sirois J; Benzerdjeb N; Mansoori BK; Grosset AA; Albadine R; Latour M; Mes-Masson AM; Hovington H; Bergeron A; Ladouceur M; Fradet Y; Saad F; Trudel D
    Prostate; 2018 Jul; 78(10):697-706. PubMed ID: 29603326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal carcinoma of the prostate.
    Szentirmai E; Giannico GA
    Pathologica; 2020 Mar; 112(1):17-24. PubMed ID: 32202536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic adenocarcinoma of ductal origin.
    Greene LF; Farrow GM; Ravits JM; Tomera FM
    J Urol; 1979 Mar; 121(3):303-5. PubMed ID: 219263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.